Glutamine: role in critical illness and ongoing clinical trials.
about
Glutamine supplementation to prevent morbidity and mortality in preterm infantsGlutamine supplementation to prevent morbidity and mortality in preterm infantsGlutamine supplementation to prevent morbidity and mortality in preterm infantsClinical review: Optimizing enteral nutrition for critically ill patients--a simple data-driven formulaPossible links between intestinal permeability and food processing: A potential therapeutic niche for glutamineTherapeutic benefits of glutamine: An umbrella review of meta-analyses.Cytokines and metabolic patterns in pediatric patients with critical illness.Protective effect of glutamine in critical patients with acute liver injuryGlutamine attenuates acute lung injury caused by acid aspirationParenteral nutrition in the critically ill patient.Amino acid composition in parenteral nutrition: what is the evidence?The protective effects of glutamine in a rat model of ventilator-induced lung injury.Oral glutamine protects against acute doxorubicin-induced cardiotoxicity of tumor-bearing rats.Development and current use of parenteral nutrition in critical care - an opinion paperGlutamine randomized studies in early life: the unsolved riddle of experimental and clinical studies.Glutamine deprivation causes enhanced plating efficiency of a herpes simplex virus type 1 ICP0-null mutant.Neuromuscular Dysfunction in Experimental Sepsis and GlutamineEnteral nutrition formulas: which formula is right for your adult patient?Hot topics in parenteral nutrition. Current evidence and ongoing trials on the use of glutamine in critically-ill patients and patients undergoing surgery.Pharmaconutrition review: physiological mechanisms.Parenteral glutamine supplementation in critical illness: a systematic review.Glutamine Supplementation in Intensive Care Patients: A Meta-Analysis of Randomized Clinical Trials.Regulation of the proteome by amino acids.When Is It Appropriate to Use Glutamine in Critical Illness?Gastrointestinal immune and microbiome changes during parenteral nutrition.Glutamine Administration in Early or Late Septic Phase Downregulates Lymphocyte PD-1/PD-L1 Expression and the Inflammatory Response in Mice With Polymicrobial Sepsis.Glutamine Supplementation in Parenteral Nutrition and Intensive Care Unit Patients: Are We Throwing the Baby Out With the Bathwater?Glutamine protects intestinal barrier function of colon epithelial cells from ethanol by modulating Hsp70 expression.Glutamine in acute lung injury: the experimental model matters.Evaluation of the effects of a preoperative 2-hour fast with maltodextrine and glutamine on insulin resistance, acute-phase response, nitrogen balance, and serum glutathione after laparoscopic cholecystectomy: a controlled randomized trial.Nutrition delivery for obese ICU patients: delivery issues, lack of guidelines, and missed opportunities.Effects of early enteral nutrition supplemented with collagen peptides on post-burn inflammatory responses in a mouse model.
P2860
Q24185892-6D9C3561-AC1F-4BE6-8A52-DF2C5990C83CQ24186518-A702018C-9169-4343-B91A-1B286949D67FQ24201195-E3EC7C04-FF44-460B-AA62-931D98F7FDEEQ26825258-B989F932-F981-45F8-BE8B-E14EF9127757Q28287402-C8FACC9E-D6F7-4E96-A277-4CE9875EA365Q33685522-8E945757-915E-4166-BF05-75D9D38929A3Q33855469-3F9BAAA4-A481-45E5-BBEF-A6105C4AE946Q34031848-2CF1C50C-730C-4C4D-861C-D4336EEDC406Q34091742-DBC69D93-5991-4F1E-BF7A-DEF0D8B6A50BQ34723274-B7D6A83A-5822-4F02-B4AA-36C699CC64A2Q34767773-0280A4B0-86F2-4B9C-B46C-F8EEAE5C3D68Q34814354-253C0DAA-D9B8-480F-9237-F5CB05553507Q35011294-96073E25-0E09-4DA5-BEF4-19598375B037Q35580680-FA5D3DAC-238C-4705-9F00-0C024D8E60EEQ36277826-5BCB53A9-E0A4-46AF-9B6A-976EEEBF8F89Q36949839-F64867C4-672C-4B1A-BFF4-C4E56C8F7264Q36983690-43CD74FA-A092-4B8A-B572-E714912669B3Q37502435-3D61E90A-AB79-4BF1-BC14-A960FB4D6B93Q37505452-FFBEB0E5-F75D-4A22-A9C6-06435736C1F0Q38134686-154E009F-37E4-4C9D-9DDA-6B398A5554F2Q38205494-842D0825-71F0-426F-9963-89A979780902Q38562404-A1D70894-E375-4F1A-8002-03015991B836Q38703345-1AE25249-7F60-407E-8224-EDD11235F865Q38849482-9479A9BD-55C4-4BF9-A67E-E0B5DED5C94FQ39116552-4E0689BA-D8EE-46D1-B563-7B95FC4FA21BQ40164934-ABD9687E-1108-48B6-B5F1-0E91C804A604Q41444401-A58C8E5A-C849-4B0F-8EEA-9E1CD9AE7A73Q44848731-B9008FCB-6433-4D3A-AB43-21A25C1683ABQ46167732-BF4762AB-7919-4BC3-9DF2-9C455153F700Q48196487-7AF3F10C-418C-44A5-BDB9-BC92CA8E3D71Q50180572-B2B01DEA-DB8A-403D-90AC-88D3D52CB4C4Q50898389-FEE0CB9B-ECE7-49A6-ADBA-6D92E6BA9E60
P2860
Glutamine: role in critical illness and ongoing clinical trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glutamine: role in critical illness and ongoing clinical trials.
@en
Glutamine: role in critical illness and ongoing clinical trials.
@nl
type
label
Glutamine: role in critical illness and ongoing clinical trials.
@en
Glutamine: role in critical illness and ongoing clinical trials.
@nl
prefLabel
Glutamine: role in critical illness and ongoing clinical trials.
@en
Glutamine: role in critical illness and ongoing clinical trials.
@nl
P1476
Glutamine: role in critical illness and ongoing clinical trials.
@en
P2093
Paul E Wischmeyer
P304
P356
10.1097/MOG.0B013E3282F4DB94
P577
2008-03-01T00:00:00Z